European shares closed higher on Monday as a soft business activity reading strengthened the case for more monetary policy ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...

AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...

Alchemab’s new CEO is the company’s co-founder and hitherto CSO, Jane Osbourn.

FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be prescribed before purchase.

By Lisa Pauline Mattackal and Shashwat Chauhan (Reuters) -UK shares ended higher on Monday after logging their worst day ...

Black Diamond Therapeutics and Ideaya Biosciences are mulling over registrational trials for their lead assets after ...

I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...

AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...

The FDA approved FluMist, a nasal spray flu vaccine for self-administration, making it the first flu vaccine of its kind available for at home use.

A cancer drug being developed by AstraZeneca failed to "achieve statistical significance" in helping patients live longer ...

For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the ...